Kirin plans to provide human antibody technology to Takeda

06-Aug-2003 - Kirin Brewery Company, Limited (Kirin) and Takeda Chemical Industries, Limited (Takeda) announced today that they have signed a licensing agreement in respect of Kirin's TC Mouse human antibody-producing technology. Under this agreement, Takeda will utilize Kirin's 'TC Mouse' human ...

Inactivation of SARS virus in blood

INACTINE Process Effectively Inactivates Both Strains of the SARS Virus

28-Jul-2003 - V.I. Technologies, Inc. a biotechnology company dedicated to developing products that improve the safety of the blood supply by pathogen reduction, announced today that its INACTINE pathogen reduction system for red blood cells was successful in inactivating the virus that causes Severe Acute ...

Henogen S.A. acquires 4C Biotech S.A.

02-Jul-2003 - Henogen, located at Charleroi in Belgium, has recently closed the acquisition of 4C Biotech, Seneffe, a Contract Manufacturing Organization dedicated to the development of mammalian cell culture processes for the production of biotherapeutics. This acquisition extends the existing services ...

Biotechnology Breakthrough for Asthma

FDA approves Xolair, the first humanized antibody to target IgE, responsible for asthma with an allergic component

24-Jun-2003 - Genentech, Inc.Novartis Pharmaceuticals Corporation and Tanox, Inc. announced that the novel IgE-blocker Xolair® (Omalizumab) for subcutaneous use has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate-to-severe persistent asthma in adults and adolescents. ...

Amarillo Bioscience, Inc. enters supply agreements in Taiwan, China and Pakistan for Maxisal(TM)

23-Jun-2003 - Amarillo Biosciences, Inc. announces supply agreements with STC International for the territories of China and Taiwan and with Majsons Corporation for the territory of Pakistan. Maxisal(TM), a patented dietary supplement, is the trade name for pharmaceutical grade anhydrous crystalline maltose, ...

Cooperation between BioVisioN and Roche Diagnostics

Roche Diagnostics is validating new marker candidates for diagnosis of Alzheimer Disease

28-May-2003 - Since entering into a cooperation project with Roche Diagnostics GmbH of Mannheim in 1999, Hanover-based biotechnology firm BioVisioN has identified a number of proteins that may enable early diagnosis of Alzheimer's Disease and distinguish it from other forms of dementia. The cooperation between ...

German biotechnology firms can win space and services in a U.S. business incubator

27-May-2003 - The Fairfax County Economic Development Authority (FCEDA) and two German biotechnology groups, Munich-based BioM AG and BioTOP Berlin Brandenburg, are holding a competition to help German biotech companies expand into the U.S. market around Washington, D.C. The deadline for entries is Saturday, ...

Monsanto executive says rigorous process for research investments balances near- and longer-term priorities

09-May-2003 - A rigorous process aligning Monsanto's research-and-development (R&D) portfolio with corporate strategy allows the company to balance its near- and longer-term priorities, according to Robert T. Fraley, Ph.D., chief technology officer. "The cross-functional process we've employed for more than a ...

Celltech announces appointment of new chief executive officer

17-Apr-2003 - Celltech Group plc today announced the appointment of Dr. Goran Ando (54) as CEO, with immediate effect. Dr. Ando served as President of R&D at Pharmacia Corporation until its acquisition by Pfizer, which completed on 15 April 2003. Dr. Ando's extensive business role as an Executive Vice ...

Dupont and Monsanto sign licensing agreement for rootworm-protected corn technology

16-Apr-2003 - DuPont and its subsidiary, Pioneer Hi-Bred International Inc., and Monsanto Company announced today they have agreed to a worldwide licensing agreement to Monsanto's recently approved YieldGard Rootworm insect-protected corn technology. "This licensing agreement allows us to provide our ...